|
CTPS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52570999999435E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.18820000000331E-05 |
| Normal-vs-Stage2 |
3.384300E-02 |
| Normal-vs-Stage3 |
1.177040E-04 |
| Normal-vs-Stage4 |
7.09709999990871E-07 |
| Stage1-vs-Stage2 |
6.114000E-01 |
| Stage1-vs-Stage3 |
3.774800E-01 |
| Stage1-vs-Stage4 |
5.282000E-02 |
| Stage2-vs-Stage3 |
3.122600E-01 |
| Stage2-vs-Stage4 |
6.908300E-02 |
| Stage3-vs-Stage4 |
2.402800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.88730000000503E-05 |
| Normal-vs-AfricanAmerican |
4.509400E-01 |
| Normal-vs-Asian |
5.980000E-03 |
| Caucasian-vs-AfricanAmerican |
3.813900E-02 |
| Caucasian-vs-Asian |
4.892200E-01 |
| AfricanAmerican-vs-Asian |
1.871550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.447400E-04 |
| Normal-vs-Female |
2.9660999999459E-06 |
| Male-vs-Female |
3.025000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.975000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.45359999999839E-05 |
| Normal-vs-Age(61-80Yrs) |
1.772770E-04 |
| Normal-vs-Age(81-100Yrs) |
1.927710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.697000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.712200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.118200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.915000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.669400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.776800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.552500E-02 |
| Classical-VS-Follicular |
2.304200E-01 |
| Classical-VS-Other |
6.943200E-01 |
| Classical-VS-Normal |
1.223390E-03 |
| Tall-VS-Follicular |
2.447600E-01 |
| Tall-VS-Other |
1.256360E-01 |
| Tall-VS-Normal |
1.77271999999284E-05 |
| Follicular-VS-Other |
4.883000E-01 |
| Follicular-VS-Normal |
3.413800E-04 |
| Other-VS-Normal |
3.385600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.65559999999654E-05 |
| Normal-vs-N1 |
3.61400000004064E-06 |
| N0-vs-N1 |
1.664570E-01 |
|
|
